For Richard “Rocky” Kimball, a diagnosis of myelodysplastic syndromes, or MDS, necessitated a number of lifestyle changes.

VEXAS syndrome is a rare adult-onset inflammatory disease linked to bone-marrow mutations. Doctors explain why it is often ...

Shattuck Labs (STTK) pivots from oncology to focus on SL-325 for inflammatory bowel disorders, following underwhelming ...

The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

LeAnn Rimes documented her experience receiving a Therapeutic Plasma Exchange—a process costing $10,000—months after her ...

Treatment with nivolumab (Opdivo) had limited benefit in patients with multiple myeloma (MM) or non-Hodkin lymphoma (NHL) ...

The forward helped support his father while he battled a rare blood cancer the last five years.

GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...

SEATTLE — Rejuvenation MD is celebrating its 12th year in business with the opening of a brand‑new practice in Puyallup—its ...

Huntington's disease is caused by an inherited genetic change that causes production of an altered protein. This leads to nerve damage in areas of the brain that control movement and thinking.

Geron Corporation (NASDAQ:GERN) is a commercial-stage biopharmaceutical company focused on developing and selling treatments for blood cancers, primarily using its first-in-class telomerase inhibitor, ...

KROS shares are up 85.6% in a year, driven by a strategic review and pipeline progress led by KER-065 and elritercept, which ...